Page 4 - Sumit Gupta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The company plans to use the proceeds of the investment to set up a new manufacturing facility near Hosur.

Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.

Maiva Pharma has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund, including both primary and secondary funding. The funds will be used to set up a new manufacturing facility near Karnataka's Hosur, with capabilities in sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. Maiva's complex injectables development and manufacturing capability, strong compliance and regulatory standards, and transparency differentiate the company from competitors.

India Business News: Maiva Pharma on Thursday said it has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund.

Scientists at the Department of Energy's Oak Ridge National Laboratory have developed a method that demonstrates how fiber-reinforced polymer composite materials used in the automotive, aerospace and renewable energy industries can be made stronger and tougher to better withstand mechanical or structural stresses over time.